Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population.
Daniel M HartungKirbee A JohnstonJessina C McGregorDennis N BourdettePublished in: International journal of MS care (2022)
Most Medicare beneficiaries with MS using DMTs face considerable out-of-pocket costs. Beneficiaries also used a significant number of medications potentially used for MS-related symptoms, although total and out-of-pocket costs were modest.